MaxCyte

(NASDAQ) MXCT

Current Price$1.16

Market Cap$122.12M

Since IPO (2019)-30%

5 Year-81%

1 Year-47%

1 Month+35%

MaxCyte Financials at a Glance

Market Cap

$122.12M

Revenue (TTM)

$32.29M

Net Income (TTM)

-$39.12M

EPS (TTM)

-$0.37

P/E Ratio

-3.11

Dividend

$0.00

Beta (Volatility)

1.40 (Average)

Dividend

$0.00

Beta (Volatility)

1.40 (Average)

Price

$1.16

Volume

608,671

Open

$1.17

Price

$1.16

Volume

608,671

Open

$1.17

Previous Close

$1.15

Daily Range

$1.15 - $1.21

52-Week Range

$0.64 - $2.38

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

1.40 (Average)

Price

$1.16

Volume

608,671

Open

$1.17

Previous Close

$1.15

Daily Range

$1.15 - $1.21

52-Week Range

$0.64 - $2.38

Estimated Earnings Date

Aug 12, 2026

MXCT News

MaxCyte (MXCT) Q2 Revenue Drops 18%

Motley Fool Markets TeamAug 6, 2025

Why Shares of MaxCyte Are Plummeting on Thursday

James HalleyOct 5, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MaxCyte

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

CEO

Maher Masoud

Website

www.maxcyte.com

Headquarters

Rockville, MD 20850, US

MXCT Financials

Key Financial Metrics (TTM)

Gross Margin

81%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-21%

Return on Capital

-21%

Return on Assets

-20%

Earnings Yield

-32.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$122.12M

Shares Outstanding

107.12M

Volume

608.67K

Avg. Volume

965.57K

Financials (TTM)

Gross Profit

$26.80M

Operating Income

-$45.29M

EBITDA

-$40.14M

Operating Cash Flow

-$34.41M

Capital Expenditure

-$1.77M

Free Cash Flow

-$36.18M

Cash & ST Invst.

$103.04M

Total Debt

$17.94M

MaxCyte Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$9.65M

-7.1%

Gross Profit

$7.07M

-20.5%

Gross Margin

73.22%

N/A

Market Cap

$122.12M

N/A

Market Cap/Employee

$1.07M

N/A

Employees

114

N/A

Net Income

-$4.75M

+53.7%

EBITDA

-$5.14M

+53.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-$2.93M

-102.5%

Accounts Receivable

$4.25M

-23.1%

Inventory

$7.63M

-7.8%

Long Term Debt

$16.11M

-8.2%

Short Term Debt

$1.37M

+7.7%

Return on Assets

-20.12%

N/A

Return on Invested Capital

-20.98%

N/A

Free Cash Flow

-$8.39M

+44.3%

Operating Cash Flow

-$8.17M

+43.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TLSITriSalus Life Sciences, Inc.

TLSITriSalus Life Sciences, Inc.$3.21+1.26%

NNOXNano-X Imaging Ltd.

NNOXNano-X Imaging Ltd.$1.82-5.70%

OWLTOwlet, Inc.

OWLTOwlet, Inc.$4.79+2.57%

SGMOSangamo Therapeutics, Inc.

SGMOSangamo Therapeutics, Inc.$0.17-19.95%

LNSRLENSAR, Inc.

LNSRLENSAR, Inc.$5.60+0.00%

PROFProfound Medical Corp.

PROFProfound Medical Corp.$6.57-1.35%

PREPrenetics Global Limited

PREPrenetics Global Limited$20.00+0.70%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SUNESUNation Energy

SUNESUNation Energy$5.88+4.20%

INHDInno

INHDInno$39.49+36.61%

NOKNokia

NOKNokia$14.59+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.26-0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.27+0.04%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.66+0.10%

NUNu Holdings

NUNu Holdings$11.60-0.03%

Questions About MXCT

What is the current price of MaxCyte?

MaxCyte is trading at $1.15 per share.

What is the 52-week range for MaxCyte?

Over the past 52 weeks, MaxCyte has traded between $0.64 and $2.38.

How much debt does MaxCyte have?

As of the most recent reporting period, MaxCyte reported total debt of $17.49M.

How much cash does MaxCyte have on hand?

MaxCyte reported $14.56M in cash and cash equivalents in its most recent financial results.

What is MaxCyte’s dividend yield?

MaxCyte does not currently have a dividend yield.

MaxCyte

MaxCyte Financials at a Glance

MXCT News

MaxCyte (MXCT) Q2 Revenue Drops 18%

Why Shares of MaxCyte Are Plummeting on Thursday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About MaxCyte

MXCT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

MaxCyte Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MXCT

What is the current price of MaxCyte?

What is the 52-week range for MaxCyte?

How much debt does MaxCyte have?

How much cash does MaxCyte have on hand?

What is MaxCyte’s dividend yield?

Premium Investing Services